These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30532247)

  • 1. High serum MMP-14 predicts worse survival in gastric cancer.
    Kasurinen A; Tervahartiala T; Laitinen A; Kokkola A; Sorsa T; Böckelman C; Haglund C
    PLoS One; 2018; 13(12):e0208800. PubMed ID: 30532247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum MMP-8 and TIMP-1 as prognostic biomarkers in gastric cancer.
    Laitinen A; Hagström J; Mustonen H; Kokkola A; Tervahartiala T; Sorsa T; Böckelman C; Haglund C
    Tumour Biol; 2018 Sep; 40(9):1010428318799266. PubMed ID: 30192205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
    Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
    BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer.
    Kasurinen A; Laitinen A; Kokkola A; Stenman UH; Böckelman C; Haglund C
    Acta Oncol; 2020 Jun; 59(6):681-688. PubMed ID: 32124669
    [No Abstract]   [Full Text] [Related]  

  • 5. High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1.
    Kasurinen A; Gramolelli S; Hagström J; Laitinen A; Kokkola A; Miki Y; Lehti K; Yashiro M; Ojala PM; Böckelman C; Haglund C
    Cancer Med; 2019 Nov; 8(16):6995-7005. PubMed ID: 31560170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
    Kushlinskii NE; Gershtein ES; Ivannikov AA; Davydov MM; Chang VL; Ognerubov NA; Stilidi IS
    Bull Exp Biol Med; 2019 Jan; 166(3):373-376. PubMed ID: 30627896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
    Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB
    Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
    Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
    Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer.
    Alakus H; Grass G; Hennecken JK; Bollschweiler E; Schulte C; Drebber U; Baldus SE; Metzger R; Hölscher AH; Mönig SP
    Histol Histopathol; 2008 Aug; 23(8):917-23. PubMed ID: 18498066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer.
    Chu D; Zhang Z; Li Y; Zheng J; Dong G; Wang W; Ji G
    Int J Cancer; 2011 Aug; 129(4):887-95. PubMed ID: 20957628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer.
    Wu T; Li Y; Lu J; Qiao Q; Bao G; Wang N; He X; Du X
    Med Oncol; 2013 Mar; 30(1):323. PubMed ID: 23275114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
    Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
    World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
    Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
    BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum matrix metalloproteinase-3 and -7 in H. pylori-related gastric cancer can be biomarkers correlating with a poor survival.
    Yeh YC; Sheu BS; Cheng HC; Wang YL; Yang HB; Wu JJ
    Dig Dis Sci; 2010 Jun; 55(6):1649-57. PubMed ID: 19690958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis.
    Hirahara N; Tajima Y; Fujii Y; Kaji S; Yamamoto T; Hyakudomi R; Taniura T; Kawabata Y
    BMC Cancer; 2018 Mar; 18(1):285. PubMed ID: 29534689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T; Xie P; Liu H
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
    Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.
    Mrena J; Wiksten JP; Nordling S; Kokkola A; Ristimäki A; Haglund C
    J Clin Pathol; 2006 Jun; 59(6):618-23. PubMed ID: 16731602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
    Schwandner O; Schlamp A; Broll R; Bruch HP
    Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.